Skip to main content
. 2012 Jul 30;21(21):4793–4804. doi: 10.1093/hmg/dds302

Figure 6.

Figure 6.

The frequency of severe (Grade 3–4) GI toxicity during consolidation therapy in the validation cohort, the Italian AIEOP-BFM-ALL 2000 and genotypes in PACSIN2; PACSIN2 SNP rs2413739 and rs737782 resulted associated with the incidence of GI toxicity in this cohort (P-values from logistic regression model, 0.032 and 0.015, respectively).